课题基金 / 基金详情

Overcoming Antibiotic Resistance by Modulating Innate Immunity

Overcoming Antibiotic Resistance by Modulating Innate Immunity
通过调节先天免疫克服抗生素耐药性
批准号:
219501
负责人:
Hancock Robert Ernest W
金额:
$0.0万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-11-01 至 2011-11-01

项目摘要

项目成果

Hancock Robert Ernest W的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The antibiotic era, stemming from the deployment of penicillin, introduced arguably the most successful medicines of all time, impacting dramatically on life expectancy by decreasing childhood and adult deaths from infections, and enabling complex surgeri
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diagnosing the onset of severe Covid-19 disease
  • 批准号:
    429307
  • 项目类别:
    Operating Grants
  • 资助金额:
    $30.75万
  • 财政年份:
    2020
  • 负责人:
    Hancock Robert Ernest W
  • 依托单位:
International Infection, Immunity and Inflammation Conference (I4C)
  • 批准号:
    404497
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.73万
  • 财政年份:
    2019
  • 负责人:
    Hancock Robert Ernest W
  • 依托单位:
Alternatives to antibiotics: New strategies for treating multi-drug resistant infections
  • 批准号:
    354182
  • 项目类别:
    Operating Grants
  • 资助金额:
    $246.73万
  • 财政年份:
    2016
  • 负责人:
    Hancock Robert Ernest W
  • 依托单位:
Pseudomonas aeruginosa: complex adaptations and adaptive resistance
  • 批准号:
    366557
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2016
  • 负责人:
    Hancock Robert Ernest W
  • 依托单位:
海外基金